Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 763

1.

Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.

Carvalho AF, Köhler CA, McIntyre RS, Knöchel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS, Berk M.

Psychoneuroendocrinology. 2015 Jul 8;62:18-26. doi: 10.1016/j.psyneuen.2015.07.002. [Epub ahead of print] Review.

PMID:
26210676
2.

Nonsuicidal self-injury in Indian adolescents: Nonexistent or unacknowledged?

Aggarwal S, Berk M.

Int J Soc Psychiatry. 2015 Aug;61(5):516-7. doi: 10.1177/0020764015579739.

PMID:
26209701
3.

Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder.

Kim SW, Dodd S, Berk L, Kulkarni J, de Castella A, Fitzgerald PB, Kim JM, Yoon JS, Berk M.

Psychiatry Investig. 2015 Jul;12(3):349-55. doi: 10.4306/pi.2015.12.3.349. Epub 2015 Jul 6.

4.

Symptoms of Depression and Difficulty Initiating Sleep From Early Adolescence to Early Adulthood: A Longitudinal Study.

Hayley AC, Skogen JC, Sivertsen B, Wold B, Berk M, Pasco JA, Øverland S.

Sleep. 2015 Jul 13. pii: sp-00724-14. [Epub ahead of print]

PMID:
26194578
5.

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

Fernandes BS, Steiner J, Bernstein HG, Dodd S, Pasco JA, Dean OM, Nardin P, Gonçalves CA, Berk M.

Mol Psychiatry. 2015 Jul 14. doi: 10.1038/mp.2015.87. [Epub ahead of print]

PMID:
26169974
6.

Evolution of optogenetic microdevices.

Kale RP, Kouzani AZ, Walder K, Berk M, Tye SJ.

Neurophotonics. 2015 Jul;2(3):031206. doi: 10.1117/1.NPh.2.3.031206. Epub 2015 Jun 25. Review.

PMID:
26158015
7.

Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample.

Hayley AC, Williams LJ, Kennedy GA, Holloway KL, Berk M, Brennan-Olsen SL, Pasco JA.

BMC Geriatr. 2015 Jul 5;15:74. doi: 10.1186/s12877-015-0068-2.

8.

Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials.

Dodd S, Schacht A, Kelin K, Dueñas H, Reed VA, Williams LJ, Quirk FH, Malhi GS, Berk M.

J Clin Psychiatry. 2015 Jun;76(6):702-11. doi: 10.4088/JCP.13r08858.

PMID:
26132671
9.
10.

Effects of N-Acetyl cysteine on suicidal ideation in bipolar depression.

Waterdrinker A, Berk M, Venugopal K, Rapado-Castro M, Turner A, Dean OM.

J Clin Psychiatry. 2015 May;76(5):e665. doi: 10.4088/JCP.14l09378.

11.

The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

Rauma PH, Pasco JA, Berk M, Stuart AL, Koivumaa-Honkanen H, Honkanen RJ, Hodge JM, Williams LJ.

J Musculoskelet Neuronal Interact. 2015 Jun;15(2):177-85.

12.

Mechanisms underlying neurocognitive dysfunctions in recurrent major depression.

Gałecki P, Talarowska M, Anderson G, Berk M, Maes M.

Med Sci Monit. 2015 May 27;21:1535-47. doi: 10.12659/MSM.893176.

13.

Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages.

Ratheesh A, Cotton SM, Betts JK, Chanen A, Nelson B, Davey CG, McGorry PD, Berk M, Bechdolf A.

J Affect Disord. 2015 Sep 1;183:45-8. doi: 10.1016/j.jad.2015.04.025. Epub 2015 Apr 22.

PMID:
26001662
14.

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study.

Hyde N, Dodd S, Venugopal K, Purdie C, Berk M, O'Neil A.

Curr Drug Saf. 2015;10(2):125-31.

PMID:
25986036
15.

Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

Panizzutti B, Gubert C, Schuh AL, Ferrari P, Bristot G, Fries GR, Massuda R, Walz J, Rocha NP, Berk M, Teixeira AL, Gama CS.

J Affect Disord. 2015 Aug 15;182:64-9. doi: 10.1016/j.jad.2014.12.010. Epub 2015 Apr 14.

PMID:
25973785
16.

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R.

Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Review.

PMID:
25957927
17.

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Maes M, Nowak G, Caso JR, Leza JC, Song C, Kubera M, Klein H, Galecki P, Noto C, Glaab E, Balling R, Berk M.

Mol Neurobiol. 2015 May 2. [Epub ahead of print]

PMID:
25934103
18.

Three paths to drug discovery in psychiatry.

Berk M, Nierenberg AA.

Am J Psychiatry. 2015 May;172(5):412-4. doi: 10.1176/appi.ajp.2014.14070858. No abstract available.

PMID:
25930130
19.

Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness.

Daglas R, Yücel M, Cotton S, Allott K, Hetrick S, Berk M.

Int J Bipolar Disord. 2015 Apr 25;3:9. doi: 10.1186/s40345-015-0024-2. eCollection 2015.

20.

Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study.

Singh AB, Bousman CA, Ng CH, Byron K, Berk M.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):53-61. doi: 10.9758/cpn.2015.13.1.53.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk